tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Sonoma Pharmaceuticals Inc

SNOA
Add to Watchlist
1.100USD
-0.030-2.65%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.98MMarket Cap
LossP/E TTM

Sonoma Pharmaceuticals Inc

1.100
-0.030-2.65%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

SNOA Financials

See Sonoma Pharmaceuticals Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Sonoma Pharmaceuticals Inc Earnings Date

Latest Release
Jun 18, 2026
EPS / Forecast
-0.33/-0.20
Revenue / Forecast
5.56M/4.59M
See Upcoming Earnings >>
Period
FY2026 Earnings
Revenue(YoY)
19.53M
36.68%
EPS(YoY)
-1.89
32.32%
Analyst Rating
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q4
FY2026Q3
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
Financial Indicators
EPS
30.39%-0.33
24.57%-0.48
45.01%-0.32
43.66%-0.76
65.45%-0.48
60.07%-0.63
89.74%-0.59
76.64%-1.34
77.30%-1.39
87.28%-1.59
---5.75
---5.75
---6.13
---12.48
---12.28
----
----
----
----
----
Revenue
48.14%5.56M
22.03%4.35M
56.58%5.60M
18.40%4.01M
9.16%3.75M
13.58%3.56M
31.05%3.58M
-1.05%3.39M
14.10%3.44M
6.59%3.14M
-18.01%2.73M
-13.96%3.43M
31.16%3.01M
1.45%2.94M
-11.03%3.33M
8.12%3.98M
6.54%2.30M
-41.21%2.90M
-35.10%3.74M
-36.12%3.68M
Net Profit
25.13%-581.00K
11.75%-819.00K
12.46%-534.00K
-8.57%-1.24M
27.27%-776.00K
-7.16%-928.00K
58.89%-610.00K
19.39%-1.14M
18.43%-1.07M
55.34%-866.00K
-45.92%-1.48M
-59.86%-1.42M
55.57%-1.31M
-105.40%-1.94M
-917.00%-1.02M
19.22%-887.00K
19.56%-2.94M
-45.23%-944.00K
-183.33%-100.00K
-557.50%-1.10M
Net Margin
49.46%-10.45%
27.68%-18.83%
44.09%-9.53%
8.30%-30.91%
33.38%-20.67%
5.65%-26.04%
68.63%-17.04%
18.54%-33.71%
28.51%-31.03%
58.10%-27.60%
---54.34%
---41.38%
---43.40%
---65.86%
---26.03%
----
----
----
----
----
Gross Margin
-3.65%39.22%
6.47%37.94%
-0.52%37.83%
-5.32%36.46%
28.30%40.70%
-23.41%35.63%
4.90%38.03%
9.62%38.51%
9.15%31.72%
62.68%46.53%
--36.25%
--35.13%
--29.06%
--28.60%
--40.95%
----
----
----
----
----
Debt to assets ratio
-1.02%1.59%
--0.00%
-32.55%0.40%
-36.16%0.95%
-26.68%1.61%
-100.00%0.00%
-52.50%0.60%
-21.22%1.49%
-17.48%2.19%
179.48%0.30%
--1.26%
--1.89%
--2.66%
--0.11%
--1.63%
----
----
----
----
----
Income Statement
Revenue
48.14%5.56M
22.03%4.35M
56.58%5.60M
18.40%4.01M
9.16%3.75M
13.58%3.56M
31.05%3.58M
-1.05%3.39M
14.10%3.44M
6.59%3.14M
-18.01%2.73M
-13.96%3.43M
31.16%3.01M
1.45%2.94M
-11.03%3.33M
8.12%3.98M
6.54%2.30M
-41.21%2.90M
-35.10%3.74M
-36.12%3.68M
Operating profit
46.49%-351.00K
34.24%-678.00K
60.35%-337.00K
6.65%-1.09M
53.44%-656.00K
-22.16%-1.03M
29.64%-850.00K
5.40%-1.17M
-24.14%-1.41M
53.70%-844.00K
-64.35%-1.21M
-94.36%-1.24M
63.15%-1.14M
-93.11%-1.82M
24.23%-735.00K
5.34%-638.00K
-7.69%-3.08M
-50.80%-944.00K
-428.81%-970.00K
-1882.35%-674.00K
Net Profit
25.13%-581.00K
11.75%-819.00K
12.46%-534.00K
-8.57%-1.24M
27.27%-776.00K
-7.16%-928.00K
58.89%-610.00K
19.39%-1.14M
18.43%-1.07M
55.34%-866.00K
-45.92%-1.48M
-59.86%-1.42M
55.57%-1.31M
-105.40%-1.94M
-917.00%-1.02M
19.22%-887.00K
19.56%-2.94M
-45.23%-944.00K
-183.33%-100.00K
-557.50%-1.10M
Balance Sheet
Current assets
-4.33%12.10M
-1.90%12.14M
2.29%12.50M
9.89%13.11M
0.80%12.65M
-0.98%12.38M
6.12%12.22M
-12.22%11.93M
-9.06%12.55M
11.31%12.50M
-7.08%11.52M
-8.30%13.59M
-16.02%13.80M
-36.54%11.23M
-31.23%12.39M
21.88%14.82M
26.55%16.43M
9.17%17.70M
10.78%18.02M
-26.41%12.16M
Total current liabilities
17.97%4.83M
13.88%4.22M
30.61%4.32M
29.25%4.85M
10.14%4.10M
20.46%3.70M
2.16%3.31M
-7.18%3.75M
0.05%3.72M
-21.86%3.07M
-8.17%3.24M
-16.75%4.04M
-36.12%3.72M
1.52%3.93M
-13.51%3.53M
-7.24%4.85M
42.69%5.82M
-0.21%3.88M
-10.75%4.08M
-7.33%5.23M
Total assets
1.95%13.96M
-0.33%13.62M
1.25%13.86M
6.74%14.59M
-7.10%13.69M
-6.50%13.67M
0.37%13.69M
-13.97%13.67M
-9.19%14.74M
4.95%14.62M
-8.87%13.63M
-7.37%15.89M
-13.87%16.23M
-28.01%13.93M
-24.54%14.96M
21.51%17.16M
25.74%18.84M
6.12%19.35M
9.28%19.83M
-21.91%14.12M
Total liabilities
17.05%10.87M
15.83%10.19M
20.83%10.07M
21.15%10.54M
7.89%9.28M
11.00%8.80M
4.69%8.33M
0.54%8.70M
4.23%8.60M
-5.29%7.93M
0.24%7.96M
-5.96%8.65M
-18.66%8.25M
2.34%8.37M
-5.10%7.94M
-3.17%9.20M
5.44%10.15M
38.26%8.18M
27.12%8.37M
28.07%9.50M
Total equity
-29.83%3.10M
-29.53%3.43M
-29.24%3.79M
-18.47%4.06M
-28.12%4.41M
-27.23%4.87M
-5.69%5.35M
-31.30%4.97M
-23.07%6.14M
20.38%6.69M
-19.17%5.67M
-9.01%7.24M
-8.28%7.98M
-50.23%5.56M
-38.73%7.02M
72.24%7.96M
62.17%8.70M
-9.31%11.17M
-0.88%11.46M
-56.67%4.62M
Cash Flow Statement
Net operating income
-446.32%-519.00K
-235.22%-764.00K
-279.38%-635.00K
-120.94%-2.02M
-162.50%-95.00K
151.18%565.00K
128.76%354.00K
-324.19%-912.00K
106.23%152.00K
-217.24%-1.10M
32.73%-1.23M
85.98%-215.00K
-74.98%-2.44M
-6.75%-348.00K
-40.34%-1.83M
-25.35%-1.53M
5.49%-1.40M
-143.70%-326.00K
-265.27%-1.30M
46.62%-1.22M
Net investment
38.30%-29.00K
-2250.00%-47.00K
61.54%-10.00K
-2020.00%-106.00K
-361.11%-47.00K
-100.00%-2.00K
-1200.00%-26.00K
70.59%-5.00K
121.95%18.00K
-102.94%-1.00K
98.93%-2.00K
26.09%-17.00K
-34.43%-82.00K
--34.00K
-1800.00%-187.00K
53.06%-23.00K
-1425.00%-61.00K
100.00%0.00
113.92%11.00K
-108.84%-49.00K
Net financing
59.92%387.00K
-70.34%210.00K
-104.29%-62.00K
-109.12%-58.00K
-61.09%242.00K
-46.28%708.00K
1219.38%1.44M
571.11%636.00K
-81.55%622.00K
514.47%1.32M
27.53%-129.00K
65.12%-135.00K
1418.92%3.37M
-168.68%-318.00K
-102.57%-178.00K
-85.17%-387.00K
-17.47%222.00K
91.32%463.00K
3148.83%6.92M
-108.09%-209.00K

FAQs

What is the total revenue of Sonoma Pharmaceuticals Inc?

According to Sonoma Pharmaceuticals Inc's FY2026 earnings report, its total revenue reached 19.53M, with a year-on-year change of 14.29M.

What are the current assets of Sonoma Pharmaceuticals Inc?

According to Sonoma Pharmaceuticals Inc's FY2026 earnings report, its current assets were 12.10M, with a year-on-year change of -4.33.

What are the total assets of Sonoma Pharmaceuticals Inc?

According to Sonoma Pharmaceuticals Inc's FY2026 earnings report, its total assets of Sonoma Pharmaceuticals Inc were 13.96M, with a year-on-year change of 1.95.

What are the total liabilities of Sonoma Pharmaceuticals Inc?

According to Sonoma Pharmaceuticals Inc's FY2026 earnings report, its total liabilities of Sonoma Pharmaceuticals Inc were 10.87M, with a year-on-year change of 17.05.

What is the total equity of Sonoma Pharmaceuticals Inc?

According to Sonoma Pharmaceuticals Inc's FY2026 earnings report, its total equity of Sonoma Pharmaceuticals Inc was 3.10M, with a year-on-year change of -29.83.

What is the net operating income of Sonoma Pharmaceuticals Inc?

According to Sonoma Pharmaceuticals Inc's FY2026 earnings report, its net operating income of Sonoma Pharmaceuticals Inc was -2.46M, with a year-on-year change of 33.67.

What is the net investment of Sonoma Pharmaceuticals Inc?

According to Sonoma Pharmaceuticals Inc's FY2026 earnings report, its net investment of Sonoma Pharmaceuticals Inc was -192.00K, with a year-on-year change of -140.00.

What is the net financing of Sonoma Pharmaceuticals Inc?

According to Sonoma Pharmaceuticals Inc's FY2026 earnings report, its net financing of Sonoma Pharmaceuticals Inc was 477.00K, with a year-on-year change of -84.26.

What is the Earnings Per Share (EPS) of Sonoma Pharmaceuticals Inc?

According to Sonoma Pharmaceuticals Inc's FY2026 earnings report, its Earnings Per Share (EPS) was -1.89, with a year-on-year change of 32.32.

What is the net income of Sonoma Pharmaceuticals Inc?

According to Sonoma Pharmaceuticals Inc's FY2026 earnings report, its net income was -3.17M, with a year-on-year change of 8.16.

What is the net margin of Sonoma Pharmaceuticals Inc?

According to Sonoma Pharmaceuticals Inc's FY2026 earnings report, its net profit margin was -16.26, with a year-on-year change of 32.81.

What is the gross margin of Sonoma Pharmaceuticals Inc?

According to Sonoma Pharmaceuticals Inc's FY2026 earnings report, its gross margin was 37.97, with a year-on-year change of -0.73.

What is the debt-to-asset ratio of Sonoma Pharmaceuticals Inc?

According to Sonoma Pharmaceuticals Inc's FY2026 earnings report, its debt-to-asset ratio was 1.59, with a year-on-year change of -1.02.

What is the Return on Equity (ROE) of Sonoma Pharmaceuticals Inc?

According to Sonoma Pharmaceuticals Inc's FY2026 earnings report, its Return on Equity (ROE) was -84.60, with a year-on-year change of -29.06.

What is the Return on Assets (ROA) of Sonoma Pharmaceuticals Inc?

According to Sonoma Pharmaceuticals Inc's FY2026 earnings report, its Return on Assets (ROA) was -22.96, with a year-on-year change of 5.57.

What is the operating profit of Sonoma Pharmaceuticals Inc?

According to Sonoma Pharmaceuticals Inc's FY2026 earnings report, its operating profit was -2.46M, with a year-on-year change of 33.67.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy